PhD Day 2024
PhD Day 2024 program (download in pdf) 8:00 -9:00 Registration 9:00 -9:30 Opening ceremony Welcome…
International Open Access Week 2022 – Webinars
-
from 24 to 30 October
#IDIBELLfellows: Romina Miranda / Marta Valle
07/10/2020 15:00-16:00
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
09/10/2020 13:00-14:00
Microsoft Teams Meeting
Career Day 2020
21/10/2020 -
21-22 October 2020
This event is being held online
La recerca en temps de pandèmia
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
21/10/2020 19:00-
VII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22/10/2020 -
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
06/11/2020 13:00-14:00
PhD Day 2020
12/11/2020 -
12-13 November 2020
this event is being held online
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
20/11/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
24/11/2020 12:00-
Xerrades Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
28/11/2020 10:00-19:00
Online i en directe:
https://sinergia.l-h.cat/
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
04/12/2020 13:00-14:00
Microsoft Teams Meeting
- 1
- 2
- 3
- …
- 33
- Entrades següents »
MACSima Imaging Platform: a complete workflow for spatial biology
Luis Muñiz, PhD – Imaging Specialist, Miltenyi Biotec Spain Hosted by Meritxell Rovira – Pancreas regeneration: pancreatic…
Thesis: Limitació de la plasticitat metabòlica per incrementar l’eficàcia dels fàrmacs inductors de dany a l’ADN en càncer
5 de desembre, 10:00 Sala Pau Viladiu, Hospital Duran i Reynals i online Tesi: Limitació de la…
#IDIBELLfellows: Gisele Priscila Soares de Aguiar & Adrián Holguín Horcajo
Deciphering the role of extracellular matrix towards amyotrophic lateral sclerosis pathogenesis Gisele Priscila Soares de Aguiar –…
Alimentació i salut: Epidemiologia nutricional
De com els estudis nutricionals ens permeten prendre consciència, tant a les autoritats com a la població…
#IDIBELLseminars: Unlocking the Brain’s Gatekeeper: LRP1/Syndapin-2 Pathway as a New Avenue for Therapy
The brain’s vasculature, with its selective endothelial cells, forms the blood-brain barrier (BBB), regulating molecular transport between…
Claves clínicas – Urgencias en neurología
7 y 14 Noviembre 2024 Aulario Facultad de Medicina, Universidad de Barcelona (Campus Bellvitge) Inscripciones: unitatem@bellvitgehospital.cat Programa
#IDIBELLseminars: How to lie with statistics to a scientist
Beyond qualitative research, all modern science is quantitative. Depending on study design, reporting results is guided by…
#IDIBELLseminars: Leveraging the tumor microenvironment to tackle Metastasis
How do tumor cells exploit the microenvironment to promote cancer progression? Over the last decades, our understanding…